Introduction
Excessive daytime sleepiness (EDS) is common and a potentially devastating public health challenge for our society. EDS is estimated to be present in up to 20% of the general population though this will vary based on definition [1] . It is a frequent complaint in sleepdeprived individuals, those with sleep disorders, and shift workers. EDS has been identified as a frequent symptom (31.4%) in common medical conditions such as peptic ulcer disease, migraine, and depression even after other variables such as age, sex, sleep time, stimulant use, smoking, and alcohol use have been considered [2 ] . Sleep disorders such as narcolepsy, idiopathic hypersomnolence, obstructive sleep apnea (OSA), and periodic limb movements of sleep are frequently associated with EDS in routine clinical practice. EDS has been shown to decrease attention, reaction time, and judgment needed for the safe operation of motor vehicles or industrial machinery [3] . Accidents can occur after seconds of somnolence, which are sometimes not perceived during monotonous tasks [4 ] . Consequently, EDS is responsible for many industrial accidents and has been recognized as a major independent risk factor involved in fatal highway accidents [5 ] . EDS has even been implicated as a potential independent cardiovascular risk factor in certain sleep conditions [6] . One study demonstrated that OSA patients with EDS have higher risk of hypertension than patients with OSA without EDS. EDS may ultimately be proven as an independent and potentially treatable factor involved in the development of cardiovascular disease in patients with known sleep disorders [7] . This may also extend to the risk of mortality [8 ] . The relationship between sleep needs and EDS is complex, particularly in the context of sleep disorders [9] . Sleep specialists not only have to deal with the medical care of patients with EDS, but are becoming increasingly involved in the legal consequences and public health management of excessive sleepiness. This underlines the importance of trustworthy objective tests to diagnose EDS. This study will highlight recent updates in the literature of testing sleepiness and vigilance in the sleep laboratory over the past few years [10, 11 ] .
Subjective tools
Subjective tools have been used to define and measure EDS. The Epworth Sleepiness Score (ESS), Stanford Sleepiness Scale (SSS), and Karolinska Sleepiness scale (KSS) are among the most widely used subjective tests Purpose of review Excessive daytime sleepiness (EDS) is common and a potentially devastating public health challenge. EDS has been implicated as a contributing factor to workplace injury, motor vehicle accidents, cardiovascular disease, and impaired quality of life. Subjective self-report measures have failed to sufficiently quantify EDS. The use of objective tools found in sleep laboratories is therefore fundamental in the management of patients with EDS. The purpose of this review is to provide an overview of the current methods used to quantify sleepiness, and to highlight recent advances.
Recent findings
The Multiple Sleep Latency Test (MSLT), normally used for the diagnosis of narcolepsy, can be a useful tool in recognizing other forms of sleepiness. The Maintenance of Wakefulness Test (MWT) has also been confirmed as an important test to identify EDS, as well as to provide an indicator of future risk of accidents. Modifications and newer tests have been discussed with potential applications for the future.
Summary
Objective tests such as the MSLT and MWT are useful in the diagnosis and management of patients with EDS. However, the relatively high cost can restrict their overall usefulness in clinical medicine. Newer simple tests are under development. [12] [13] [14] . Recently, a new scale has been developed focusing on subjective EDS analysis at different points in the day: the Time of Day Sleepiness Scale. This measure may be useful to assess circadian features of EDS [15] .
Keywords
EDS can vary across cultures depending on the measurement tool. The Multi-Ethnic Study of Atherosclerosis showed that measurement of ethnic differences in EDS may result in different estimates of subjective sleepiness based on definition [16] . Some cultures include a daytime nap (siesta) in the daily routine. The tolerability of EDS in these populations may ultimately delay the identification and treatment of predisposing medical conditions. Though subjective tools can provide useful screening information, the lack of sensitivity and specificity of these tests continues to impact their overall clinical utility [17 ,18] . Furthermore, subjective tests are subject to bias, and motivation or secondary gain of patients may influence the reported results.
Objective tools
Objective tools are crucial for both diagnosis and management of EDS. The most commonly used tests to measure EDS in the sleep laboratory setting include the Multiple Sleep Latency Test (MSLT) and Maintenance of Wakefulness Test (MWT). Less commonly actigraphy and the Psychomotor Vigilance Test (PVT) [19] [20] [21] [22] are used.
The American Academy of Sleep Medicine (AASM) has established practice parameters for the MSLT and MWT. The MSLT is a validated objective measure of the ability or tendency to fall asleep and is particularly useful in the evaluation of patients with suspected narcolepsy or idiopathic hypersomnia. The MSLT is not routinely appropriate for evaluation of sleepiness in most other medical or neurological disorders. The MWT is a validated objective measure of the ability to stay awake for a defined time and may be useful for the assessment of individuals in whom alertness represents a safety issue. This test can also be used to assess response to therapy in conditions such as narcolepsy or idiopathic hypersomnia. The 40-min MWT protocol is recommended when the sleep clinician requires objective data to assess an individual's ability to remain awake. Table 1 shows a summary of MSLT and MWT characteristics and recommendations based on the AASM practice parameters [21] . Both tests are to be interpreted in the appropriate clinical context by a trained sleep physician.
The choice of the MSLT or MWT can be influenced by motivation. Individuals can more readily increase sleep latency on the MSLT, and decrease latency on the MWT [23] . This may influence test selection when motivation represents a significant confound.
The MSLT is not routinely recommended for the initial evaluation and diagnosis of OSA syndrome, or in the assessment of change following treatment with nasal continuous positive airway pressure. Repeat MSLT testing may be useful when the initial test was inadequately performed or when ambiguous or uninterpretable findings are present, and when the patient is suspected to have narcolepsy, but earlier MSLT evaluation(s) did not provide confirmation of this suspicion.
Extensive normative data are not available for pediatric use of these tests and this represents an important unmet need. Recent work has shown that children with attention deficit have objectively increased sleepiness as measured by the MSLT [24] .
Update on the Multiple Sleep Latency Test
The MSLT is the most studied test to measure EDS and the most work has been done on further refining this test and developing it as a clinical tool. A recent study confirms a high degree of conformity among various raters using the MSLT for the diagnosis of narcolepsy. There was also high inter-rater and intra-rater consistency in the determination of sleep latency and sleep-onset rapid 
Key points
The need for trustworthy objective tools that are able to identify excessive daytime somnolence is important given the high prevalence of this condition and the potentially devastating public health consequences of unrecognized sleepiness. [25] . In narcolepsy, the MSLT has also been shown to have some correlation with subjectively poor sleep quality as determined by subjective number of awakenings, and subjective sleepiness as determined by the Epworth Sleepiness Scale [26] .
The quantity and quality of sleep before and during the MSLT have drawn some concern. The amount of sleep before the MSLT, and microsleep during the interval tests of MSLT have been identified as potential confounding issues [27, 28] . Relative sleep deprivation prior to the MSLT and sleep during the MSLT could significantly impact the results and subsequent clinical conclusions. Recent studies have focused on characterizing sleep in the 2-week period of time prior to the MSLT. Actigraphy may be helpful as a tool to convey this information as it is more objective in comparison to a sleep log. Brief sleep was measured in another study between naps during the MSLT. Sleep between the tests was demonstrated in approximately 20% of patients, but neither clinical nor electrophysiological differences were found to be significant in this group of patients [29] .
Recent studies have focussed on the use of the MSLT in the diagnosis and differentiation of behaviorally induced insufficient sleep syndromes and various kinds of central nervous system hypersomnias. Sleepiness and REM tendency were more likely in narcolepsy than in behaviorally induced insufficient sleep syndrome. Marti et al. [30] demonstrated that patients with narcolepsy were more likely to have a non-REM1 (NREM1) to REM to NREM2 progression in their MSLT sleep architecture compared to behaviorally induced insufficient sleep syndrome. Another study showed that based on a definition of sleep onset (single epoch of stage 1 NREM sleep versus three epochs or another sleep stage), the authors could detect differences in idiopathic hypersomnia compared to narcolepsy patients, with the narcolepsy patients having earlier sustained sleep. Attention to this subtle change in definition provided a high sensitivity and specificity for distinction between the two disease entities [31 ] . Although guidelines suggest repeat MSLT testing in situations in which a suspected narcolepsy diagnosis is not confirmed physiologically, there has been little evidence to support this approach. A small retrospective study analyzed the detection of a narcolepsy diagnosis upon repeated MSLT. A second MSLT confirmed the diagnosis in 20% of patients with inconclusive results on their first study. This study showed that repeat MSLT can be useful in patients with high clinical suspicion of narcolepsy despite an indeterminate first test [32 ] .
One group has recently used an engineering approach on a single channel of electroencephalography (EEG) data from the polysomnogram or MSLT to generate an automated measure of sleepiness that predicts sleep latency [33 ] . This approach is important, as it will help facilitate rapid assessment of large EEG/MSLT data sets for the purpose of sleepiness research in a variety of conditions.
Whereas some work has gone into the subtlety of test administration, the assessment of the MSLT's prediction of 'real world' outcomes such as accident risk is extremely important. One study demonstrated that the MSLT could detect changes in alertness with simple interventions such as caffeine use or a nap [34] . A recent study of 618 people demonstrated that the MSLT could predict an increased risk of motor vehicle crashes in the general population [35 ] . Use of the MWT in this scenario might have been even more sensitive to this finding given that the MWT is more commonly used to assess the ability to remain alert. Another study looking at the ability of the MSLT to predict novel outcomes showed that in myotonic dystrophy, individuals with two or more SOREMPs had greater muscular impairment [36] .
Update on the Maintenance of Wakefulness Test
Some work has explored the acceptable duration of time needed on an MWT to diagnose impaired wakefulness. The situation of increased motivation in patients hoping to retain their license has suggested that shorter duration of testing (20 versus 40 min) may not be sufficient to identify accident risk in this scenario and that more stringent criteria be applied in the form of the 40-min test [37, 38] .
Detailed analysis of the collected MWT data may also yield further information than is readily apparent by visual inspection in order to improve utility. A study that used Fourier analysis of the EEG collected during the MWT showed that specific EEG spectral power changes (increases in delta, and decreases in alpha and beta) were associated with a failure to communicate sleepiness [39 ] .
The MWT has been recognized as a potentially better tool for the prediction of motor vehicle accidents and other complications of EDS. It has been suggested that low MWT times are directly correlated to driving impairment and accidents. Studies using a driving simulator have shown that individuals with MWT mean sleep latency times greater than 34 min perform adequately, whereas those with MWT mean sleep latency times below 19 min have a higher risk of motor vehicle accidents [40] . Another study suggested differences could be detected in drivers with a mean sleep latency under 34 min [41] . A study of military personnel showed that even mild-to-moderate OSA and upper airway resistance syndrome were often associated with impaired alertness on the MWT and could therefore represent a significant risk [42] . One study of continuous positive airway pressure in OSA did not demonstrate improved alertness on the MWT in a dose-response manner based on compliance data, though the authors detail several possible reasons for this finding in their article [43] .
Newer tests for the assessment of sleepiness
Actigraphy is an objective surrogate method of broadly assessing wakefulness versus sleep that has also been considered. Although the detection of movement is a marker of alertness, it is not sufficiently sensitive in most clinical cases. However, actigraphy may be a useful research tool in assessing 'real-world' alertness. Actigraphy estimates sleep periods in patients with a suspicion of sleep disorders by measuring movement over longer periods than the MSLT or MWT, a key advantage of this technology [44] . It has been extensively used as a tool in studying patients with circadian rhythm disorders given its ability to track data over days to weeks. The combination of clinical history and actigraphy increases the sensitivity of this tool. Actigraphy can be a useful tool to determine circadian patterns and estimate regular daily sleep time prior to implementation of standard tests in patients with EDS [44] .
The Psychomotor Vigilance Test (PVT) is an extensively studied tool used in the quantification of alertness that is sensitive to sleep loss and circadian variation [45] . The PVT is simple to perform and has a high sensitivity for identifying daytime sleepiness. The PVT was used on the International Space Station to determinate daily effects of fatigue and sleepiness on crew performance during a recent mission. Typically the test requires a response to a visual stimulus for 10 consecutive minutes with stimuli presented at random time intervals. The elapsed time for each response is recorded, as are number of lapses -defined as a lack of response for a prolonged, arbitrary duration, typically 500 ms. The neural basis of lapses of attention has recently been explored and likely represents a return to the 'default mode' of the brain [46] .
By also considering eye movement characteristics, further characterization of lapses may reveal details about the level of disengagement and provide further clues to the sleep onset process [47 ] . A rigorous study of 74 healthy individuals attempted to discern the optimal methods of distinguishing sleepiness in sleep-deprived individuals and has suggested that some shorter versions of the test may be sensitive to sleep loss and could be developed further [48 ] .
Other techniques are less amenable for routine clinical use at present. Multiple other markers of sleepiness have been considered. Studies of gait stability have been of particular interest given the association of falls in the elderly with sedative medications and the functional recovery implications in stroke patients with sleep disorders. A recent study demonstrated that control of balance varies depending on time of day, indicating that this process is dependent on sleep/circadian factors as well as neuromuscular function. In the future it may be possible to quantify EDS according to balance changes or anticipate balance disturbances after sleep deprivation [49] . Another study suggested that a 3-min balance assessment may allow prediction of fatigue based on postural control [50] . A distinct advantage to an approach such as this will be the ability to repeat the test frequently.
The Pupillographic Sleepiness Test (PST) is another objective instrument to quantify EDS. PST is a noninvasive test that measures spontaneous pupillary oscillations while in a dark room; pupil size and variability are markers of the level of arousal [51] .
Evoked potentials can be easily obtained in most clinical neurophysiology laboratories. Increased amplitudes of auditory evoked potentials, especially the N2 component, have been found during monotonous tasks and sleepy circumstances [52] .
The DQB1Ã0602 human leukocyte antigen (HLA) haplotype, a commonly used genetic marker of narcolepsy, can also be implicated in predicting general population differences in basal alertness and sleep deprivation circumstances [53 ] . Further genetic markers of sleepiness are likely to be developed over time.
Other techniques may more rapidly be amenable to current laboratory assessment with appropriate softwarebased computational tools. The detection of slow eye movements (SEMs) as an indicator of sleep onset may eventually be used to simplify the MSLT [54, 55 ] . This method requires minimal equipment and has been shown to be an indicator of sleep latency in OSA patients.
Conclusion
The lack of sensitivity and specificity of current subjective measures limits their use in the approach to EDS. Objective measurement techniques, specifically the MSLT and MWT, have proven to be helpful methods of diagnosing, managing and following the treatment of EDS and associated disorders. However, EDS is a complex symptom and thus unlikely to be completely explained by any one of the current methods of testing. Numerous refinements of the MSLT and MWT will help improve applicability of the test in a variety of clinical and research scenarios. Further development of a dependable and easily performed test will be important for the future if we hope to successfully manage the public health burden of EDS.
